Clinical trials recruiting for Chronic kidney disease

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
  NCT07239570 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
  NCT05321368 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Clinical Study to Map the HLA Genomic Region in the Greek Population
  NCT06227468 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
  NCT07348237 · Phase: Phase 1 · Ages: 24 Years to 85 Years · Sex: All (male and female) · 3 locations
• A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
  NCT06578078 · Phase: Phase 3 · Ages: 70 Years and older · Sex: All (male and female) · 6 locations
• A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
  NCT06799936 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial
  NCT07361146 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 65 Years · Sex: All (male and female) · 1 location
• A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
  NCT06310967 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
  NCT06343727 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Long-Term Follow-Up Study of Participants Exposed to REACT
  NCT05918523 · Phase: Not specified · Ages: 30 Years to 80 Years · Sex: All (male and female) · 1 location
• A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
  NCT07496177 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Natural History Study of Metabolic Sizing in Health and Disease
  NCT05398783 · Phase: Not specified · Ages: 2 Years to 99 Years · Sex: All (male and female) · 1 location
• A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
  NCT06126016 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
  NCT07619820 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · 79 locations
• A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
  NCT06466785 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 58 locations
• A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
  NCT03969329 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 23 locations
• A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
  NCT07419828 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 771 locations
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 186 locations
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 71 locations
• A Pilot Study of The CKM JumpStart Tool
  NCT05753020 · Phase: Not applicable (e.g. observational or device study) · Ages: 75 Years and older · Sex: All (male and female) · 2 locations
• A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
  NCT05515367 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
  NCT06642272 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• A Prospecitve Multicenter, Observational Registry Study
  NCT07481526 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 59 locations
• A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
  NCT05188885 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 147 locations
• A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
  NCT07561957 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 30 Years · Sex: All (male and female) · 2 locations
• A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
  NCT06173323 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
  NCT07223502 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
  NCT07494409 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
  NCT07487727 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Luspatercept in People With Anemia
  NCT07725497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
  NCT06243731 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
  NCT07619157 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 2 locations
• A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
  NCT07241390 · Phase: Phase 3 · Ages: 50 Years and older · Sex: All (male and female) · 566 locations
• A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
  NCT07136792 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 24 locations
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
  NCT07268638 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
  NCT07275788 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure
  NCT07047547 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
  NCT05970172 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 47 locations
• A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
  NCT06933472 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 42 locations
• A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
  NCT07559396 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 44 locations
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 31 locations
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
  NCT03619850 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 21 locations
• A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
  NCT04671771 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · 21 locations
• A Study to Evaluate the Safety, Tolerability and PK of SK-08
  NCT07021157 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 93 locations
• A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
  NCT07231679 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 715 locations
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 10 locations
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
  NCT06942910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
  NCT07577817 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
  NCT06721143 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body
  NCT07722585 · Phase: Phase 1 · Ages: 18 Years to 58 Years · Sex: All (male and female) · 1 location
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · 151 locations
• A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
  NCT03633708 · Phase: Phase 3 · Ages: 0 Years to 18 Years · Sex: All (male and female) · 43 locations
• A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
  NCT07262333 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
  NCT07187713 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• AI-Guided Relaxation for Hemodialysis Anxiety
  NCT07522944 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
  NCT07210021 · Phase: Not specified · Ages: 22 Years and older · Sex: All (male and female) · 1 location
• AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
  NCT04392206 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• APOL1 Genetic Testing in African Americans
  NCT05656261 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 139 locations
• Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
  NCT05655325 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · 2 locations
• Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
  NCT06598436 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Acoustic Analysis of VA Sounds
  NCT05612022 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Activated Charcoal Use in Chronic Kidney Disease Patients
  NCT06906874 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
  NCT05266092 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Acute Equol Supplementation and Vascular Function in Women With and Without CKD
  NCT06128278 · Phase: Phase 2 · Ages: 50 Years to 69 Years · Sex: Female · 1 location
• Adding Urea to the Final Dialysis Fluid
  NCT06366230 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
  NCT07572890 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients
  NCT07045064 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 60 Years · Sex: All (male and female) · 2 locations
• Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
  NCT07173062 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
  NCT04185844 · Phase: Not specified · Ages: 21 Years to 80 Years · Sex: All (male and female) · 3 locations
• An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients
  NCT06542016 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
  NCT06032208 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
  NCT06754280 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 80 Years · Sex: All (male and female) · 1 location
• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
  NCT05106387 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 9 locations
• An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
  NCT07232537 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
  NCT06278207 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
  NCT07554469 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
  NCT07072468 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Analysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment
  NCT07438002 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
  NCT07380113 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
  NCT04500665 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
  NCT04708587 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 84 Years · Sex: All (male and female) · 1 location
• Arterial Stiffness in Children and Young People With Hypertension and Chronic Kidney Disease
  NCT07768865 · Phase: Not specified · Ages: 10 Years to 25 Years · Sex: All (male and female) · 1 location
• Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
  NCT07180368 · Phase: Not specified · Ages: 65 Years and older · Sex: All (male and female) · 4 locations
• Assessment of Kidney Function by Electrical Impedance Tomography (EIT)
  NCT06898294 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
  NCT07141043 · Phase: Not specified · Ages: 20 Years to 70 Years · Sex: All (male and female) · 1 location
• Assessment of Protein Intake Using 2 Types of Nutritional Collection in Chronic Kidney Disease.
  NCT06224153 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
  NCT06474169 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Assessment of the Impact of Repeated Ischemic Preconditioning Episodes on Hemodynamic and Metabolic Parameters in Patients at Various Stages of Chronic Kidney Disease
  NCT07746102 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Association Between Biomarkers and Kidney Function Decline in Pulmonary Hypertension
  NCT06409624 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Automated Insulin Delivery in Adults With Advanced Kidney Disease
  NCT06463483 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• BIOmarkers Before and After Kidney Transplantation
  NCT06810258 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• BLOOM: Biological Legacy of Origin in Mother-Infant Dyads
  NCT02000895 · Phase: Not specified · Ages: Up to 10 Years · Sex: All (male and female) · 1 location
• BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
  NCT07118683 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 9 locations

Related conditions

Trials recruiting for Chronic kidney disease often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Chronic kidney disease trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.